272 related articles for article (PubMed ID: 11259611)
1. Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics.
Sunami A; Glaaser IW; Fozzard HA
Mol Pharmacol; 2001 Apr; 59(4):684-91. PubMed ID: 11259611
[TBL] [Abstract][Full Text] [Related]
2. A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel.
Sunami A; Glaaser IW; Fozzard HA
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2326-31. PubMed ID: 10681444
[TBL] [Abstract][Full Text] [Related]
3. Novel structural determinants of mu-conotoxin (GIIIB) block in rat skeletal muscle (mu1) Na+ channels.
Li RA; Ennis IL; Vélez P; Tomaselli GF; Marbán E
J Biol Chem; 2000 Sep; 275(36):27551-8. PubMed ID: 10859326
[TBL] [Abstract][Full Text] [Related]
4. Sodium channel selectivity filter regulates antiarrhythmic drug binding.
Sunami A; Dudley SC; Fozzard HA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14126-31. PubMed ID: 9391164
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
[TBL] [Abstract][Full Text] [Related]
6. Specificity for block by saxitoxin and divalent cations at a residue which determines sensitivity of sodium channel subtypes to guanidinium toxins.
Favre I; Moczydlowski E; Schild L
J Gen Physiol; 1995 Aug; 106(2):203-29. PubMed ID: 8537816
[TBL] [Abstract][Full Text] [Related]
7. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.
Kimbrough JT; Gingrich KJ
J Physiol; 2000 Nov; 529 Pt 1(Pt 1):93-106. PubMed ID: 11080254
[TBL] [Abstract][Full Text] [Related]
8. Pore residues critical for mu-CTX binding to rat skeletal muscle Na+ channels revealed by cysteine mutagenesis.
Li RA; Tsushima RG; Kallen RG; Backx PH
Biophys J; 1997 Oct; 73(4):1874-84. PubMed ID: 9336183
[TBL] [Abstract][Full Text] [Related]
9. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific external paths for lidocaine, defined by isoform-specific residues, accelerate recovery from use-dependent block.
Lee PJ; Sunami A; Fozzard HA
Circ Res; 2001 Nov; 89(11):1014-21. PubMed ID: 11717158
[TBL] [Abstract][Full Text] [Related]
11. Exploring the structure of the voltage-gated Na+ channel by an engineered drug access pathway to the receptor site for local anesthetics.
Lukacs P; Gawali VS; Cervenka R; Ke S; Koenig X; Rubi L; Zarrabi T; Hilber K; Stary-Weinzinger A; Todt H
J Biol Chem; 2014 Aug; 289(31):21770-81. PubMed ID: 24947510
[TBL] [Abstract][Full Text] [Related]
12. Dependence of mu-conotoxin block of sodium channels on ionic strength but not on the permeating [Na+]: implications for the distinctive mechanistic interactions between Na+ and K+ channel pore-blocking toxins and their molecular targets.
Li RA; Hui K; French RJ; Sato K; Henrikson CA; Tomaselli GF; Marbán E
J Biol Chem; 2003 Aug; 278(33):30912-9. PubMed ID: 12764145
[TBL] [Abstract][Full Text] [Related]
13. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of the putative pore region of the rat IIA sodium channel.
Kontis KJ; Goldin AL
Mol Pharmacol; 1993 Apr; 43(4):635-44. PubMed ID: 8386312
[TBL] [Abstract][Full Text] [Related]
15. On the structural basis for size-selective permeation of organic cations through the voltage-gated sodium channel. Effect of alanine mutations at the DEKA locus on selectivity, inhibition by Ca2+ and H+, and molecular sieving.
Sun YM; Favre I; Schild L; Moczydlowski E
J Gen Physiol; 1997 Dec; 110(6):693-715. PubMed ID: 9382897
[TBL] [Abstract][Full Text] [Related]
16. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
[TBL] [Abstract][Full Text] [Related]
17. Properties of the mutant Ser-460-Cys implicate this site in a functionally important region of the type IIa Na(+)/P(i) cotransporter protein.
Lambert G; Forster IC; Stange G; Biber J; Murer H
J Gen Physiol; 1999 Nov; 114(5):637-52. PubMed ID: 10532962
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide-gated channels. Pore topology studied through the accessibility of reporter cysteines.
Becchetti A; Gamel K; Torre V
J Gen Physiol; 1999 Sep; 114(3):377-92. PubMed ID: 10469728
[TBL] [Abstract][Full Text] [Related]
19. A tryptophan residue (W736) in the amino-terminus of the P-segment of domain II is involved in pore formation in Na(v)1.4 voltage-gated sodium channels.
Carbonneau E; Vijayaragavan K; Chahine M
Pflugers Arch; 2002 Oct; 445(1):18-24. PubMed ID: 12397382
[TBL] [Abstract][Full Text] [Related]
20. Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin.
Zhang MM; Gruszczynski P; Walewska A; Bulaj G; Olivera BM; Yoshikami D
J Neurophysiol; 2010 Jul; 104(1):88-97. PubMed ID: 20410356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
